Docket #: S22-428
Plasma Biomarkers of Vestibular Schwannoma
Stanford researchers in the Konstantina Stankovic Lab have developed a panel of blood biomarkers for vestibular schwannoma diagnosis and hearing loss monitoring associated with this intracranial tumor. Nine immune-related biomarkers (TNR-R2, MIF, CD30, MCP-3, IL-2R, BLC, TWEAK, eotaxin, S100B) make up the excellent discriminatory panel with 90.6% sensitivity and 75% specificity for diagnosing vestibular schwannoma (VS). Although histologically benign, VS causes hearing and balance loss, and can be life-threatening if left unchecked. Diagnosis and tumor management is monitored via lengthy and costly is contrast-enhanced MRI and may be insufficient to determine the ideal timing for tumor resection to prevent progressive hearing loss. Monitoring the Stankovic Lab panel of VS blood biomarkers is faster, safer, less expensive, and potentially more effective in determining treatment options, including whether and when to operate on a vestibular schwannoma to maximize the likelihood of hearing preservation and minimize the likelihood of hearing loss.
Stage of Development
Proof of Concept
Applications
- Customized multiplex immunoassays for rapid patient screening and vestibular schwannoma monitoring.
Advantages
- Rapid, safe, and potentially more sensitive molecular diagnosis and monitoring of vestibular Schwannoma compared to the 'gold-standard' MRI. 90.6% sensitivity and 75% specificity for diagnosing vestibular schwannoma.
Publications
- Vasilijic, S., Atai, N., Hyakusoku, H., Worthington, S., Ren, Y., Sagers, J. E., ... & Stankovic, K. M. (2023). Identification of Immune-Related Candidate Biomarkers in Plasma of Patients with Sporadic Vestibular Schwannoma. bioRxiv, 2023-01.
Related Links
Patents
- Published Application: WO2024103000
Similar Technologies
-
Method for generating human spiral ganglion neurons S22-419Method for generating human spiral ganglion neurons
-
Telomere Length as a Diagnostic Biomarker for Cardiomyopathy S15-422Telomere Length as a Diagnostic Biomarker for Cardiomyopathy
-
Unsupervised identification, matching, display and quantitation of subsets (clusters) by exhaustive projection pursuit methods S18-146Unsupervised identification, matching, display and quantitation of subsets (clusters) by exhaustive projection pursuit methods